Skip to main content
Premium Trial:

Request an Annual Quote

Advaita Receives $125K Grant to Commercialize Bioinformatics Software

NEW YORK (GenomeWeb) – Advaita Bioinformatics has received a $125,000 matching grant from the Michigan Emerging Technology Fund, administered through the Michigan Small Business Development Center.

Plymouth, Mich.-based Advaita is using the grant along with another $125,000 in third-party funds to commercialize software for analyzing and interpreting genetic data. These funds give Advaita the requisite resources to bring its product to the research and pharmaceutical market, Sorin Draghici, Advaita's president and CEO, said in a statement.

"We have already seen incredible interest for our software and have established a number of key partnerships that will be announced next month," Draghici said. "These are expected to greatly increase customer use and adoption of our software."

Earlier this year, Advaita received a $1.8 million phase II Small Business Innovation Research grant from the National Institute of General Medical Sciences to develop and implement a new method of identifying disease subtypes and subgroups of patients within disease phenotypes.

Filed under

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.